Rubra Medicaments reports standalone net profit of Rs 0.01 crore in the September 2021 quarter

Sales rise 188.89% to Rs 0.26 crore

Net profit of Rubra Medicaments remain constant at Rs 0.01 crore in the quarter ended September 2021 and also during the previous quarter ended September 2020. Sales rose 188.89% to Rs 0.26 crore in the quarter ended September 2021 as against Rs 0.09 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales0.260.09 189 OPM %7.6911.11 -PBDT0.020.01 100 PBT0.020.01 100 NP0.010.01 0

Powered by Capital Market - Live News